Yang, Yang
Lee, Sang-Min
Imamura, Fumiaki
Gowda, Krishne
Amin, Shantu
Mailman, Richard B.
Funding for this research was provided by:
Brain and Behavior Research Foundation (Young Investigator Grant)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01 MH040537, U19 MH082441)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01 NS105471)
the Penn State Hershey Neuroscience Institute; the Parkinson’s Disease Gift Fund of the Penn State Milton S. Hershey Medical Center
Article History
Received: 13 October 2017
Revised: 14 November 2018
Accepted: 15 November 2018
First Online: 7 December 2018
Compliance with ethical standards
:
: RBM has a potential conflict-of-interest related to his role as an inventor on patents related to dopamine D<sub>1</sub> agonists, the ownership of which has been assigned to university foundations. These issues are managed by the Conflict-of-Interest system at the Penn State University and its College of Medicine. The remaining authors declare that they have no conflict of interest.